Cancer genomes with mutations in the exonuclease domain of Polymerase Epsilon 21 (POLE) present with an extraordinarily high somatic mutation burden. In vitro studies 22 have shown that distinct POLE mutants exhibit different polymerase activity and yet, 23 how these POLE mutants generate mutations across cancer genomes and influence 24 driver events remains poorly understood. Here we analyzed 7,345 colorectal cancer 25 samples, including nine whole genome sequenced samples harboring POLE mutations. 26 Our analysis identified differential mutation spectra across the mutants including 27 methylation-independent enrichment of C>T mutations in POLE V411L. In contrast, 28 analysis of other genomic regions showed similar mutation profiles across the 29 different POLE mutants. Notably, we found that POLE mutants with the TP53 R213* 30 mutation, caused by a TT[C>T]GA substitution, have significantly higher relative 31 frequency of this mutational context compared with samples without this mutation.
7 methylation measured is between 90% and 100%, but decreases when the level of 135 CpG methylation level is equal 100%. We examined whether sequencing coverage, 136 replication timing or repeat sequences in different methylation levels contributes to 137 this change, but found that they were not associated with this observation ( Figure   138 2-figure supplement 1). We then tested the composition of penta-nucleotide contexts 139 at different levels of methylation, since C>T mutations are also enriched in specific 140 penta-nucleotide context as discussed above (Figure 1-figure supplement 2) . We 141 found that there are more CpGs in the TTCGN context in the 90-100% CpG 142 methylation bin compared with the 100% CpG methylation bin, accounting for 8.67% supplement 2). Following normalization for penta-context composition across the 145 different bins, the mutation rate at the 90-100% bin decreased by 17.6% (Other-Exo), 146 18.04% (V411L) and 20.02% (P286R) POLE mutants respectively, making the 147 mutation rate in this bin more similar to that of the 100% methylated CpG sites 148 (Figure 2-figure supplement 3) . This finding again demonstrates that different 149 preferences for penta-nucleotide context within POLE mutants can account for 150 differences in the observed mutational patterns.
152
Distinct POLE mutants show similar genome-wide mutational patterns 153 Characterization of mutations in CTCF binding sites 154 CCCTC-binding factor (CTCF) is a transcription factor and plays an essential role in 155 constructing three-dimensional genome organization. Somatic mutations in CTCF 156 binding sites of the CTCF-cohesin complex (CBS) are widely observed in cancer 8 (Katainen et al., 2015) , but the mutation rate of distinct POLE mutants has not been 160 examined. We calculated mutation counts at each position within 1000 nucleotides 161 from the CTCF motif center and we identified a distinct pattern whereby mutation 162 burden was significantly decreased in all the three mutants ( Figure 3A) . For each 163 mutant, mutation load starts to decline approximately 110 nucleotides from the CTCF 164 motif center, and then presents a significant lower mutation frequency than expected 165 by chance within the center of the CTCF motif, especially at the central cytosine Mutation density around the transcription start site 173 We also investigated mutation density around the transcription start site (TSS) in 174 different POLE mutants. The DNA sequence around the TSS can show distinct 175 mutation patterns, as active promoters are occupied with transcription factors, which 176 may inhibit DNA repair access or activity (Perera et al., 2016, Sabarinathan et al., 177 2016). We examined mutation profiles of C>T, C>A and T>G mutations around TSSs 178 for each POLE mutant. Notably, before normalization, T>G mutations were 179 substantially decreased at the TSS (Figure 3-figure supplement 2) . However, 180 following normalization for trinucleotide sequence context, this was no longer evident, 181 and we only observed substantial decrease in C>T mutations close to the TSS likely Exonic regions show decreased mutation burden in POLE mutants 185 Increased mismatch repair (MMR) activity at exons compared with introns has been 186 shown to result in a significant decrease in exonic mutation rate in MMR proficient 187 POLE mutants (Frigola et al., 2017) . We investigated mutation patterns of exonic and 188 intronic regions in different POLE mutants ( Figure 3C) . All three kinds of POLE 189 mutants showed decreased mutation rates in exonic region. Particularly in P286R The minor groove of DNA that wraps around nucleosomes presents a differential 207 pattern due to its physical interaction with histones, and this pattern determines 208 periodicity in mutation rate (Brown et al., 2018 , Pich et al., 2018 . Colorectal cancers 209 10 with contribution from signature 10 have been reported to exhibit a positive minor-in 210 relative increase of mutation rate as a consequence of interaction between the 211 processes of DNA damage and repair within the nucleosome (Pich et al., 2018) . We 212 investigated mutation rate periodicity in each specific POLE mutant separately, and 213 we observed the positive minor-in relative increase of mutation rate in all POLE 214 mutants to comparable levels, suggesting that the different POLE mutant induced 215 mutations are not differentially affected by DNA-histone interactions ( Figure   216 3-figure supplement 4).
218
Increased mutation rate at late replication timing 219 Finally, the mutation rate in late-replicating regions should be higher than in 220 early-replicating regions in MMR proficient cancer samples due to differential MMR 221 efficiency (Supek and Lehner, 2015) . Although all POLE mutants showed high 222 mutational burden, they are MMR proficient with a microsatellite stable phenotype.
223
The mutation burden of a range of mutational signatures have been associated with 224 DNA replication timing, and a significant correlation with replication timing has been 225 reported in cancer samples with POLE mutant associated mutational signature 10 226 (Tomkova et al., 2018) . We calculated mutation rate in genomic region with distinct 227 replication timings. As expected, all mutants similarly displayed higher mutation rates Mutational context of POLE-mutants predisposes colorectal cancers to 232 developing TP53 R213* mutation hotspots 233 Since we had identified that different POLE mutants have different mutation spectra, 234 11 we next sought to determine whether this may predispose cells to specific additional 235 cancer driver mutations. We screened a list of 47 cancer driver mutation hotspots, 236 determined based on recurrence in cohorts where we could access mutation calls in an 237 unbiased manner (see Methods), in a total of 7,345 colorectal cancer samples pentanucleotide context differs between individual samples, we compared its relative 252 frequency in POLE mutants with and without the TP53 R213* mutation. This 253 mutational context was found to not only be significantly higher in POLE P286R 254 mutants with the TP53 R213* mutation compared with those without this mutation (P 255 = 0.0088, Student's t-test, Figure 4D ), but also significantly higher across all POLE 256 mutants with the TP53 R213* mutation compared with those without this mutation (P 257 = 0.0161, Student's t-test, Figure 4E ). This suggests that for C>T mutations, POLE In this study, we investigated genome-wide regional mutational profiles of different 264 POLE mutants, as well as their influence on driver mutation formation in cancer.
265
Genomes with POLE functional defects present with differential mutation spectra but 266 show largely similar regional mutational profiles. Significantly, we identified a 267 recurrent nonsense mutation in TP53 that is enriched in P286R mutants, indicating a 268 new insight into mutational processes of specific POLE mutants.
269
All POLE mutants had frequent C>A, C>T and T>G mutations in TCT, TCG and 270 TTT contexts respectively, which is consistent with the classic POLE signature.
271
However, we found that POLE V411L mutants carry significantly more C>T 272 mutations genome-wide than other mutants (V411L vs P286R, P<0.001, Chi-squared 273 test). V411L and P286R are the two most frequent POLE mutants and they are located of other residues adjacent to the active site (Briggs and Tomlinson, 2013) . In yeast,
279
POLE mutants with a weak exonuclease activity have more C>T and less C>A 280 mutations than mutants with no exonuclease activity (Xing et al., 2019) . We therefore 281 speculate that the proportionally reduced C>A and increased C>T mutation loads in 282 V411 may arise due to stronger exonuclease activity, as the mutation is distal from 283 that site. Consistent with this, in a cell free system, V411L was found to have 3-fold 284 13 reduced exonuclease activity compared to wild-type, while P286R mutants displayed 285 a 10-fold reduction (Shinbrot et al., 2014) . 286 Methylated cytosine have been shown to readily mutate to thymine as a result of 287 methylcytosine deamination (Sassa et al., 2016) . We found that although V411L had 288 comparably more mutations at the cytosine of CpG dinucleotides than P286R and 289 other POLE mutants (16.68% (V411L), 6.38% (P286R) and 10.19% (Other-Exo)), all 290 mutants showed the same positive association with methylation level after adjusting 291 for total CpG mutation count. Therefore, although methylation is an important 292 determinant of CpG mutagenesis, the CpG sequence context is particularly favorable 293 for mutagenesis in the V411L mutants. In addition, we observed unusually high 294 mutation rate at methylation levels between 90-100%. As most C>T mutations are 295 enriched in the specific TTCGN context, we demonstrate that the composition of 296 contexts in different methylation level can influence the mutation burden.
297
Altered POLE enzyme function could result in substantial mutation accumulation, 298 and we observed uneven distribution of mutations at local regions in different mutants.
299
CBSs are frequently mutated across different cancer types, and are a major mutational 300 hotspot in noncoding cancer genomes (Katainen et al., 2015) . CTCF binding sites 301 display a specific mutation pattern in skin cancers due to differential nucleotide 302 excision repair (Poulos et al., 2016) . We observed decreased mutation density at and 303 adjacent to CBSs, and the decline starts at around 110 nucleotide distance from the 304 center of the CBS. It has been proposed that the decrease in mutation density in this 305 region might be due to either the use of an alternative polymerase (Katainen et al., 306 2015). CTCF-cohesin binding sites might be treated like DNA-protein crosslinks 307 during replication, so they get bypassed with the help of an accessory helicase RTEL1 308 and is later filled by translesion synthesis (Sparks et al., 2019) . Finally, disparity in 309 14 mutation rate between exon and intron regions, and early and late replication timing 310 regions were identified in all POLE mutants, although the effect appeared strongest in 311 the P286R mutants, possibly due to the higher mutation burden in these samples. 312 These results suggest that mismatch repair is an important system to protect against 313 POLE replication errors regardless of subtle differences in the way the mutations were 314 generated. Overall, in-depth analysis of mutation patterns with respect to a vast array 315 of genomic and epigenetic features revealed largely unchanged mutation patterns 316 between different POLE mutants suggesting that these factors that affect mutagenesis 317 do not strongly interact with the biochemistry of the enzyme to modify their 318 mutagenic effects.
319
Mutational signatures representing the spectrum of different somatic mutations 320 can be employed to decipher the mutational process that operated within an individual 321 cancer (Alexandrov et al., 2013b) . Recent studies have revealed the associations 322 between mutational processes and somatic driver mutations to some extent, and 323 indicated that altered tri-nucleotide preferences arising from a certain signature would 324 increase the likelihood of the associated driver mutation arising (Poulos et al., 2018 , 325 Temko et al., 2018 . Previous studies have identified an association between the TP53 326 R213* truncating mutation and POLE mutant cancers (Shinbrot et al., 2014 , Poulos et 327 al., 2017 . Our study has further identified that this TP53 hotspot is significantly 328 enriched in POLE P286R mutants (62.5%) in colorectal cancer. The TP53 R213* 329 truncating mutation is caused by a C>T transition in a TTCGA penta-nucleotide 330 context, and we found that POLE mutants with this mutation do generally have higher 331 relative frequency of this mutational context compared to POLE mutants without this 332 mutation. This implies a possible direct causal relationship between POLE-associated 333 mutagenesis and acquisition of this driver mutation. 334 
15
In summary, understanding how specific driver mutation may arise could lead to 335 new targeted therapeutic strategies. This study has shown the importance of further 336 subtyping cancers, not only focusing on the mutated genes, but also the specific 337 mutations within those particular genes. Stratifying samples based on DNA 338 polymerase activity defects has enabled us to gain a better understand the mutational 339 processes in colorectal cancer genomes. The profile of each signature was displayed using the six substitution subtypes: C>A, 366 C>G, C>T, T>A, T>C and T>G. For signature generated by tri-nucleotide context, 367 each substitution was examined by incorporating information on the bases 368 immediately 5' and 3' to each mutated base to generate 96 possible mutation types.
369
For signature generated by penta-nucleotide context, each substitution was examined 370 by incorporating information of two nucleotides at 5' and 3' to each mutated base Katainen et al., 2015) . Each CTCF motif was extended to 1000 bp on each side, 395 and the mutation profiles were generated by counting mutations that are intersected 396 with these sequences at each base. In order to obtain expected counts that are affected 397 by fraction of distinct contexts, the following procedures were conducted. First, the 398 count (M) of each mutated context was calculated in the overall extended sequences.
399
Then, the abundance of each context in the whole extended sequence was computed 
